Plenary Session

/Plenary Session

Plenary Session

09:30-09:50 Aharon Aharon, CEO, Israel Innovation Authority

09:50 – 10:50 Corporate Panel: Corporate Investing: Can Strategics Rescue Cash-Starved Start-Ups?
Moderator: David Cassak, Managing Partner, Innovation In Medtech
Michael Martin, PhD, Global Head, Takeda Ventures, Inc.
Zeev Zehavi, Vice President of Venture Investments, Johnson & Johnson Innovation – JJDC, Inc. (JJDC)
Gil Bar-Nahum, PhD, Managing Director, Jefferies International, London, UK
Michal Silverberg, Managing Director, Novartis Venture Fund
Simon Gisby, Managing Director, Deloitte Corporate Finance LLC
David Neustaedter, Vice President, Venture Capital Medtronic
William Shen, Executive Director, Business Development, Bristol-Myers Squibb

10:50-11:30 Bruce R. Rosengard, MD, Vice President, External Innovation, Medical Devices, Johnson and Johnson Medical Devices:  “Innovation: Challenges and Creative Solutions”

By | 2018-05-07T16:00:22+00:00 March 12th, 2018|Comments Off on Plenary Session

About the Author: